报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 54.28% | -7.54% | 0.22% | 65/128 | 53.28% | 佰仁医疗 | 88.56% | 行业排名> |
2024-06-30 | 54.15% | -7.03% | 1.55% | 67/128 | 53.52% | 佰仁医疗 | 89.27% | 行业排名> |
2024-03-31 | 53.33% | -6.52% | -7.81% | 65/128 | 53.62% | 佰仁医疗 | 89.28% | 行业排名> |
2023-12-31 | 57.84% | 0.88% | -1.46% | 58/128 | 53.72% | 正海生物 | 89.9% | 行业排名> |
2023-09-30 | 58.7% | 0.35% | 0.77% | 57/128 | 54.06% | 正海生物 | 90.39% | 行业排名> |
2023-06-30 | 58.25% | -0.48% | 2.12% | 57/128 | 53.61% | 正海生物 | 90.3% | 行业排名> |
2023-03-31 | 57.04% | -0.41% | -0.51% | 58/128 | 53.66% | 正海生物 | 89.78% | 行业排名> |
2022-12-31 | 57.34% | 3.78% | -1.98% | 58/128 | 53.93% | 三友医疗 | 90.18% | 行业排名> |
2022-09-30 | 58.5% | 6.67% | -0.06% | 59/128 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
2022-06-30 | 58.53% | 8.07% | 2.19% | 62/128 | 54.68% | 三友医疗 | 90.29% | 行业排名> |
2022-03-31 | 57.28% | 13.07% | 3.67% | 63/128 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
2021-12-31 | 55.25% | 6.65% | 0.75% | 75/128 | 57.3% | 三友医疗 | 90.5% | 行业排名> |
2021-09-30 | 54.84% | 3.8% | 1.25% | 68/128 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
2021-06-30 | 54.16% | 5.01% | 6.92% | 74/128 | 58.42% | 正海生物 | 90.78% | 行业排名> |
2021-03-31 | 50.66% | 2% | -2.22% | 69/128 | 60.75% | 正海生物 | 91.59% | 行业排名> |
2020-12-31 | 51.8% | 5.14% | -1.94% | 83/128 | 59.64% | 正海生物 | 92.23% | 行业排名> |
2020-09-30 | 52.83% | 2% | 2.43% | 64/128 | 61.59% | 正海生物 | 92.69% | 行业排名> |
2020-06-30 | 51.58% | 12.79% | 4.67% | 78/128 | 59.94% | 正海生物 | 92.61% | 行业排名> |
2019-12-31 | 49.27% | 7.13% | 7.13% | 71/128 | 56.28% | 正海生物 | 94.38% | 行业排名> |
2018-12-31 | 45.99% | -9.31% | 0.58% | 69/128 | 55.53% | 正海生物 | 93.12% | 行业排名> |
2018-06-30 | 45.73% | 2% | -9.83% | 32/128 | 51.56% | 正海生物 | 93.78% | 行业排名> |
2017-12-31 | 50.72% | 2% | 2% | 59/128 | 55.34% | 正海生物 | 93.09% | 行业排名> |